Comprehensive analysis of lysine crotonylation modification in patients with chronic renal failure

Jiahuang Huang1, Donge Tang1, Fengping Zheng1

  • 1Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease,, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen People's Hospital,, Guangdong, 518020, Shenzhen, P.R. China.

BMC Nephrology
|September 14, 2021
PubMed
Abstract

Insights

This study reveals altered protein crotonylation in chronic renal failure (CRF) patients, identifying key modifications and pathways. These findings suggest crotonylation

Area of Science:

  • Biochemistry and Molecular Biology
  • Proteomics
  • Renal Physiology

Background:

  • Post-translational modifications (PTMs) regulate protein function and cellular signaling.
  • Crotonylation is a significant PTM involved in diverse biological processes.
  • The role of lysine crotonylation in chronic renal failure (CRF) remains unexplored.

Purpose of the Study:

  • To investigate the global lysine crotonylation proteome in patients with chronic renal failure.
  • To identify differentially crotonylated proteins and associated biological pathways in CRF.

Main Methods:

  • Comparative analysis of crotonylation proteomes between normal controls and CRF patients.
  • Utilized liquid chromatography-tandem mass spectrometry (LC-MS/MS).
  • Employed highly sensitive immune-affinity purification for site identification.

Main Results:

  • Identified 1109 lysine modification sites, with 772 up-regulated and 69 down-regulated in CRF.
  • Crotonylation levels are elevated in CRF patients.
  • Enriched pathways include platelet alpha granule lumen, degranulation, cell adhesion molecule binding, and CD36 signaling, linked to renal failure.

Conclusions:

  • This is the first global analysis of the crotonylation proteome in CRF.
  • Altered crotonylation of histone and non-histone proteins may influence renal function.
  • Potential role of crotonylation in mitigating the progression of chronic kidney disease.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
142
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
171
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.0K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
220
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
92
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
850